Current State of Drug Development, Clinical Trials, and Precision Measures
Drug research and development can cost up to $6bn per asset and take an average of 13 years from discovery to approval1. In this expensive…
Pharma Technology
What’s the State of AI-enabled Automation in Pharma R&D?
Smart automation promises to transform life sciences research and development operations, and streamline pharma companies’ path to market while enhancing patient safety. But how far…
3PARL Consortium to Assure Global Life Sciences Industry of High Standard of GMP Supply Chain Audits
The new Third-Party Audit Report Library (3PARL®) consortium, founded by Rephine and Eurofins Healthcare, aims to set a benchmark for life sciences manufacturing supply chain…
Unlocking the Advantages of eCTD 4.0 Compliance
The long-awaited eCTD 4.0 standard is now available, though it is not yet mandatory. Life sciences companies can tap into the detail of the standard…
Importance of the Multimode Plate Reader in the Field of Scientific Research
A multimode plate reader is a device used to read and analyse culture or test plates in biological or chemical experiments, it can detect two…
Regulatory Considerations in Technology for Decentralised Clinical Trials – Navigating evolving regulations
Decentralised clinical trials (DCTs) are not new, though their popularity and utilisation has grown since the COVID-19 pandemic. DCTs are enabled by and mutually reinforce…
Ritualising Medication Consumption: Transforming Medication Intake through Social and Habitual Delivery Mechanisms
Rituals play a significant role in human lives, offering a sense of structure, routine, and meaning to our daily actions. While rituals are commonly associated…
How Pharma Companies can Accelerate Customer Engagement Post-pandemic
Throughout the 2020s, pharmaceutical companies have been thrust under the spotlight like never before. Fortunately, they’ve largely responded exceptionally, delivering life-saving vaccine treatments at record…
Ensuring End-to-end Quality and Safety through Third Party Supplier Management
With disruption to the traditional supply chain, managing quality and safety in today’s complex and ever-changing global Life Sciences market can be a challenge. In…
Data Quality Governance in Life Sciences: 5 Misconceptions to Overcome
Over time Life Sciences regulatory processes will become increasingly data focused, driven by cross-functional data connectivity requirements and the growing need for structured data submission…